FIESCH, Switzerland

Pietro Scalfaro

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Enyo Pharma. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pietro Scalfaro. Retrieved from https://idiyas.com/inventor/pietro-scalfaro-663rukcc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pietro Scalfaro: Innovator in Pharmaceutical Research

Introduction

Pietro Scalfaro is an accomplished inventor based in Fiesch, Switzerland. He is currently associated with Enyo Pharma, where he contributes to innovative research in the pharmaceutical field. Although he does not have any granted patents, his work is focused on developing novel treatments for various medical conditions.

Latest Patent Applications

Pietro Scalfaro has been involved in several significant patent applications. One of his latest applications is titled "Synergistic Effect of a FXR Agonist and IFN for the Treatment of HBV Infection." This invention relates to a synergistic combination of an FXR agonist and interferon for the treatment of hepatitis B. Another notable application is "Method for Treating Chronic Kidney Diseases," which outlines a method for treating chronic kidney diseases.

Conclusion

Pietro Scalfaro is a dedicated inventor whose work at Enyo Pharma focuses on advancing pharmaceutical treatments. His latest patent applications reflect his commitment to addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…